Viewing Study NCT01300858


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2025-12-25 @ 10:25 PM
Study NCT ID: NCT01300858
Status: TERMINATED
Last Update Posted: 2015-07-13
First Post: 2011-02-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients
Sponsor: EGEN, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-06
Start Date Type: None
Primary Completion Date: 2014-07
Primary Completion Date Type: ACTUAL
Completion Date: 2014-07
Completion Date Type: ACTUAL
First Submit Date: 2011-02-18
First Submit QC Date: None
Study First Post Date: 2011-02-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-07-13
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2015-06-15
Last Update Post Date: 2015-07-13
Last Update Post Date Type: ESTIMATED